On Tuesday, Vancouver city council began weighing what could be one of the more contentious decisions of their four-year term ...

TikTok is unquestionably a modern phenomenon that features dancing, pranks, challenges, and unites the world with cat and dog ...

Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated with Dravet syndrome and Lennox-Gastaut ...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced an upcoming poster presentation on ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...

Presenter: Ruchi P. Patel, Ph.D., Research and Development Scientist Presentation Date and Time: Monday, December 9, 2024, 6:00 PM-8:00 PM PT ...

Rakovina Therapeutics will host a video conference call on Wednesday, November 27, 2024, at 10am PST to further discuss the data presented at the Society for Neuro-Oncology Annual Meeting and discuss ...

Initiation of a single, two-part, pivotal Phase 3 trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anticipated by YE’24 Phase 2 MaGic trial of DNTH103 in generalized ...

Foreign ministers from the world's leading industrialized nations are meeting Monday, with a certain pressure to advance diplomatic efforts ahead of the new U.S. administration taking over.

Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r adverse risk AML patients selected for oral presentation on Saturday, December 7 th – – Ziftomenib combined with ven/aza in R/R NPM1-m or KMT2A-r ...